Co Diagnostics Correlations
| CODX Stock | USD 0.33 0.04 10.81% |
The current 90-days correlation between Co Diagnostics and enVVeno Medical Corp is 0.09 (i.e., Significant diversification). The correlation of Co Diagnostics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Co Diagnostics Correlation With Market
Average diversification
The correlation between Co Diagnostics and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Co Diagnostics and DJI in the same portfolio, assuming nothing else is changed.
Moving against CODX Stock
| 0.34 | VZ | Verizon Communications Aggressive Push | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CODX Stock performing well and Co Diagnostics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Co Diagnostics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AEMD | 7.66 | (0.19) | 0.00 | 0.17 | 0.00 | 12.86 | 142.93 | |||
| NVNO | 5.61 | (3.04) | 0.00 | (0.57) | 0.00 | 4.62 | 72.08 | |||
| ALUR | 3.29 | (0.71) | 0.00 | (0.24) | 0.00 | 7.32 | 26.93 | |||
| XAIR | 4.90 | (0.67) | 0.00 | (0.29) | 0.00 | 7.52 | 73.04 | |||
| SINT | 5.71 | 0.19 | 0.03 | 0.27 | 6.68 | 12.17 | 42.50 | |||
| DWTX | 4.22 | 0.16 | 0.04 | 0.14 | 4.99 | 7.78 | 55.52 | |||
| TNON | 2.60 | (0.37) | 0.00 | (0.12) | 0.00 | 5.98 | 17.46 | |||
| PRPH | 5.59 | (0.11) | 0.00 | 0.02 | 6.90 | 12.00 | 56.45 | |||
| VVOS | 3.42 | (0.90) | 0.00 | 10.88 | 0.00 | 10.24 | 21.01 | |||
| ADGM | 5.18 | (0.65) | 0.00 | (0.19) | 0.00 | 14.56 | 41.94 |
Co Diagnostics Corporate Management
| Christopher Thurston | Chief Officer | Profile | |
| Andrew Benson | Head Relations | Profile | |
| Mayuranki Almaula | Senior Alliances | Profile | |
| Dan CPA | Vice Accounting | Profile | |
| Ivory Chang | Chief Officer | Profile |